Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.

MLA

Kramer, Jennifer R., et al. “Treatment of Hepatitis C Virus Infection in People with Opioid Use Disorder: A Real-World Study of Elbasvir/Grazoprevir in a US Department of Veterans Affairs Population.” The American Journal of Drug and Alcohol Abuse, vol. 48, no. 4, July 2022, pp. 445–53. EBSCOhost, https://doi.org/10.1080/00952990.2021.1983821.

APA

Kramer, J. R., Puenpatom, A., Cao, Y., Yu, X., El-Serag, H. B., & Kanwal, F. (2022). Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. The American Journal of Drug and Alcohol Abuse, 48(4), 445–453. https://doi.org/10.1080/00952990.2021.1983821

Chicago

Kramer, Jennifer R, Amy Puenpatom, Yumei Cao, Xian Yu, Hashem B El-Serag, and Fasiha Kanwal. 2022. “Treatment of Hepatitis C Virus Infection in People with Opioid Use Disorder: A Real-World Study of Elbasvir/Grazoprevir in a US Department of Veterans Affairs Population.” The American Journal of Drug and Alcohol Abuse 48 (4): 445–53. doi:10.1080/00952990.2021.1983821.